24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cytogenetics<br />

donation program <strong>of</strong> possibly “expanded” trinucleotids <strong>of</strong> this region<br />

provides greater security to the receptor patients in our processing <strong>of</strong><br />

Assisted Reproduction.<br />

P03.156<br />

Fragile X syndrome screening <strong>of</strong> families with consanguineous<br />

and non-consanguineous parents in the iranian population<br />

S. Abedini 1 , A. Pouya 1 , N. Mansoorian 2 , F. Behjati 1 , N. Nikzat 1 , M. Mohseni 1 , S.<br />

Esmaeeli Nieh 3 , L. Abbasi 3 , H. Darvish 1 , G. Bahrami Monajemi 1 , S. Banihashemi<br />

1 , R. Kariminejad 2 , K. Kahrizi 1 , H. Ropers 3 , H. Najmabadi 1,2 ;<br />

1 <strong>Genetics</strong> Research Center, University <strong>of</strong> Social Welfare and Rehabilitation<br />

Sciences, Tehran, Islamic Republic <strong>of</strong> Iran, 2 Kariminejad-Najmabadi Pathology<br />

and <strong>Genetics</strong> Center, Tehran, Islamic Republic <strong>of</strong> Iran, 3 Max Planck Institute for<br />

Molecular <strong>Genetics</strong>, Berlin, Germany.<br />

Fragile X syndrome is the most common form <strong>of</strong> inherited mental retardation<br />

(MR). It is caused by the expansion <strong>of</strong> CGG triplet repeats in<br />

the fragile X mental retardation 1 (FMR1) gene. In mentally retarded<br />

males, the frequency <strong>of</strong> fragile X syndrome is approximately 2 to 3<br />

percent, but little is known about its proportion in mentally retarded<br />

patients from countries where parental consanguinity is common.<br />

The objective <strong>of</strong> this study was to estimate the frequency <strong>of</strong> fragile X<br />

syndrome (FXS) in mentally retarded patients from Iran. We examined<br />

a total <strong>of</strong> 508 families with MR that had been referred to the <strong>Genetics</strong><br />

Research Center (GRC) in Tehran. 467 <strong>of</strong> these families had at<br />

least two mentally retarded children, and in 384 families, the parents<br />

were related. Full FMR1 mutations were found in 32 <strong>of</strong> the 508 families<br />

studied (6.3%), in 19 out <strong>of</strong> 124 families with apparently unrelated<br />

parents (15.3%), and in 13 <strong>of</strong> the 384 consanguineous families (3.4%).<br />

Thus, in Iran, the relative frequency <strong>of</strong> FXS seems to be higher than<br />

in Central Europe and other Asian countries, and much higher in patients<br />

with unrelated parents. We also show that even in families with<br />

consanguineous parents, FXS has to be ruled out before assuming<br />

that familial MR is due to autosomal recessive gene defects. Molecular<br />

studies are in progress to explain the high proportion <strong>of</strong> FMR1 mutations<br />

in mentally retarded <strong>of</strong>fspring <strong>of</strong> unrelated Iranian parents.<br />

P03.157<br />

simultaneous analysis <strong>of</strong> FmR1 and ARX genes improves the<br />

efficiency <strong>of</strong> the fragile X screening.<br />

F. Martinez, S. Oltra, I. Ferrer-Bolufer, M. Roselló, S. Monfort, C. Orellana;<br />

Hospital Universitario La Fe, Valencia, Spain.<br />

Fragile X syndrome is the most frequent form <strong>of</strong> inherited mental retardation,<br />

caused by the expansion <strong>of</strong> a CGG triplet in the FMR1 gene.<br />

On the other hand, microduplications or expansions in ARX gene,<br />

leading to elongations <strong>of</strong> a polyalanine tract, are considered the second<br />

most frequent cause <strong>of</strong> X-linked mental retardation. However, the<br />

genetic screening <strong>of</strong> this gene is not routinely performed.<br />

We conducted a prospective analysis <strong>of</strong> both genes, by the simultaneous<br />

amplification <strong>of</strong> FMR1 exon 1 and a fragment <strong>of</strong> ARX gene where<br />

the polyalanine elongations cluster, in a total <strong>of</strong> 700 developmentally<br />

retarded males remitted for fragile-X screening.<br />

We found nine unrelated cases with the fragile X syndrome and three<br />

index cases (four patients) with ARX elongations. Given the relative<br />

frequencies between both genes and the prevalence <strong>of</strong> the fragile-X<br />

expansions (about 1:5,000 males), the prevalence <strong>of</strong> ARX elongations<br />

can be estimated in 1:15,000 males.<br />

The duplex analysis we propose <strong>of</strong>fers several advantages: 1) An increased<br />

sensitivity <strong>of</strong> the fragile-X screening in about 30%, with no<br />

substantial cost increment. 2) As large fragile-X expansions cannot be<br />

detected by PCR, the amplification <strong>of</strong> another fragment with similar<br />

size, GC content and presence <strong>of</strong> repeats, serves as internal reference<br />

to differentiate mutations (expansions or deletions) from technical pitfalls.<br />

3) Similarly, weak co-amplification <strong>of</strong> a normal FMR1 allele can<br />

be suggestive <strong>of</strong> mosaicism with full mutation. Although rare, mosaic<br />

cases represent a limitation <strong>of</strong> any PCR-based method for the screening<br />

<strong>of</strong> the fragile-X expansion.<br />

P03.158<br />

FmR2 protein, whose absence causes the FRAXE associated<br />

mental retardation, is a splicing factor<br />

B. Bardoni 1 , M. Melko 1 , J. Gecz 2 , E. Lalli 1 , M. Bensaid 1 ;<br />

1 Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France, 2 Department<br />

<strong>of</strong> Genetic Medicine, Women’s and Children’s Hospital,, Adelaide,<br />

Australia.<br />

FRAXE is a form <strong>of</strong> mild to moderate mental retardation due to the<br />

silencing <strong>of</strong> the FMR2 gene. The cellular function <strong>of</strong> FMR2 protein<br />

is presently unknown. By analogy with its homologue AF4, FMR2<br />

was supposed to have a role in transcriptional regulation, but robust<br />

evidences supporting this hypothesis are lacking. We observed that<br />

FMR2 co-localizes with the splicing factor SC35 in nuclear speckles,<br />

the nuclear regions where splicing factors are concentrated, assembled<br />

and modified. Similarly to what was reported for splicing factors,<br />

blocking splicing or transcription leads to the accumulation <strong>of</strong> FMR2 in<br />

enlarged, rounded speckles. FMR2 is also localized in the nucleolus<br />

when splicing is blocked. We have recently shown that FMR2 is able<br />

to specifically bind the G-quartet-forming RNA structure with high affinity.<br />

Remarkably, in vivo, in the presence <strong>of</strong> FMR2 the ESE (Exonic<br />

Splicing Ehnancer) action <strong>of</strong> the G-quartet situated in mRNA <strong>of</strong> an alternatively<br />

spliced exon <strong>of</strong> a minigene or <strong>of</strong> the putative target FMR1<br />

(fragile X Mental retardation & gene) appears reduced. Indeed, the<br />

absence <strong>of</strong> FMR2 does not affect the total expression <strong>of</strong> FMR1 mRNA<br />

but increases the expression <strong>of</strong> the is<strong>of</strong>orms containing exon 14 and<br />

encoding a protein localized in the cytoplasm. The role <strong>of</strong> FMR2 in<br />

splicing is not exclusive to its role in transcriptional regulation, since we<br />

cannot exclude that the function <strong>of</strong> FMR2 is modulated by the interaction<br />

with transcription factors, as, shown, for example, for SWI/SNF,<br />

a complex involved both in chromatin remodelling and regulation <strong>of</strong><br />

alternative splicing.<br />

P03.159<br />

Post axial polidactily and costo-vertebral anomalies in a 31<br />

years old woman with 1qter chromosome deletion.<br />

M. Bertoli, F. Gullotta, S. Considera, V. Brugiati, S. Zampatti, C. Catalli, G.<br />

Novelli, M. Frontali, A. Nardone;<br />

U.O.C. Laboratorio di Genetica Medica Policlinico Tor Vergata, Roma., Rome,<br />

Italy.<br />

Subtelomeric deletion <strong>of</strong> long arm <strong>of</strong> chromosome 1 is described as<br />

a recognisable syndrome presenting with mental retardation, microcephaly,<br />

growth retardation, a characteristic facial appearance, corpus<br />

callosum abnormalities, cardiac, gastro-oesophageal and urogenital<br />

defects (van Bon et al., 2008).<br />

We describe a 31 years old women with a de novo 1qter deletion. We<br />

have seen her for the first time at 30 years, identified 1qter deletion by<br />

subtelomeric analysis, and characterized the size <strong>of</strong> the deletion by<br />

CGH array..<br />

She was born to healthy unrelated parents, pregnancy was complicated<br />

with threatened abortion and growth delay (at term: weight 2.300<br />

gr, length 48 cm, OFC 31 cm). She presented with severe hypotonia,<br />

cianosis, cleft palate, post-axial polydactyly <strong>of</strong> left foot, bilateral clubfoot,<br />

and dysmorphic features including bulbous nasal tip, thin lips and<br />

left preauricular tag. Echocardiography revealed interventricular septal<br />

defect. Thoracic X-Rays showed dorsal vertebral clefts (D4, D5 and<br />

D6), and rib fusions (I and II, V and VI, VII and VIII at left and VIII and<br />

IX at right). Ectopic left kidney and albinoid fundus oculi were also<br />

present. Since the first months <strong>of</strong> life she had generalized seizures<br />

treated with anticonvulsivants. This is the oldest patient with 1qter deletion<br />

described to date. Her phenotype includes features not reported<br />

so far such as polydactyly and ribs fusions and confirms that vertebral<br />

anomalies, previously described in 2 patients only, are not uncommon<br />

elements <strong>of</strong> the syndrome.<br />

P03.160<br />

Evaluation <strong>of</strong> a case with 5p deletion syndrome<br />

F. Mutlu Içduygu, H. Şamli, K. Hekimler, A. Özgöz, Y. Sivaci, N. Imirzalioğlu;<br />

Afyon Kocatepe University, School <strong>of</strong> Medicine, Department <strong>of</strong> Medical <strong>Genetics</strong>,<br />

Afyon, Turkey.<br />

The case is the second child <strong>of</strong> the couple who made third cousin marriage.<br />

She had a healthy elder brother. The case was born with a birth<br />

weight <strong>of</strong> 2,720 kg and a height <strong>of</strong> 52 cm. Her growth retardation was<br />

realized at the age <strong>of</strong> 8 months. The case was physically examined<br />

and a pedigree was drawn. Metaphase plaques were obtained from<br />

peripheral blood lymphocytes <strong>of</strong> the case cultered for 72 hours and<br />

evaluated after GTL banding. The findings <strong>of</strong> the case were congenital<br />

malformation, mental retardation, cat-like cry at the first 1-2 weeks<br />

after birth, SGA (small for gestational age), growth retardation, microcephaly,<br />

strabismus, micrognathia, stridor, low set ears, high arched

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!